A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue.

Suppr

超能文献

作者信息

Stoller R G, Kaplan H G, Cummings F J, Calabresi P

出版信息

Cancer Res. 1979 Mar;39(3):908-12.

PMID:311683

Abstract

摘要

相似文献

A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue.

Cancer Res. 1979 Mar;39(3):908-12.

Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.

Cancer Res. 1982 Sep;42(9):3896-900.

Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexate.高剂量甲氨蝶呤暴露后人体骨髓中胸苷和亚叶酸解救的细胞动力学比较。

Cancer Res. 1979 Apr;39(4):1315-20.

High-dose methotrexate with leucovorin rescue.大剂量甲氨蝶呤联合亚叶酸钙解救。

Cancer Nurs. 1978 Aug;1(4):319-25.

High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study.高剂量甲氨蝶呤联合亚叶酸钙解救治疗卵巢癌：一项II期研究。

Cancer Treat Rep. 1979 Feb;63(2):275-9.

High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.

Cancer Treat Rep. 1977 Jul;61(4):691-4.

Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.

Cancer Treat Rep. 1978 Sep;62(9):1295-304.

Phase I trial of high-dose methotrexate with modified citrovorum factor rescue.大剂量甲氨蝶呤联合改良亚叶酸钙解救的I期试验

Cancer Treat Rep. 1978 Mar;62(3):397-9.

[Treatment of malignant neoplasms in advanced stages with HDMTX-CF Rescue (high-dose methotrexate-citrovorum factor rescue)].

Clin Ter. 1981 May 15;97(3):271-81.

High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.

Cancer Treat Rep. 1977 Aug;61(5):779-83.

引用本文的文献

Overview of Methotrexate Toxicity: A Comprehensive Literature Review.甲氨蝶呤毒性概述：一项全面的文献综述

Cureus. 2022 Sep 23;14(9):e29518. doi: 10.7759/cureus.29518. eCollection 2022 Sep.

Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.体外治疗甲氨蝶呤中毒：EXTRIP 工作组的系统评价和建议。

Clin J Am Soc Nephrol. 2022 Apr;17(4):602-622. doi: 10.2215/CJN.08030621. Epub 2022 Mar 2.

Mechanisms, Management and Prevention of Pemetrexed-Related Toxicity.培美曲塞相关毒性的机制、管理与预防

Drug Saf. 2021 Dec;44(12):1271-1281. doi: 10.1007/s40264-021-01135-2. Epub 2021 Nov 6.

A Case of Methotrexate Neurotoxicity Presented as Status Epilepticus, Encephalopathy, and High Fever.一例以癫痫持续状态、脑病和高热为表现的甲氨蝶呤神经毒性病例。

J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619862311. doi: 10.1177/2324709619862311.

Pharmacokinetics of methotrexate administered via the hepatic artery.

Cancer Chemother Pharmacol. 1981;5(4):217-20. doi: 10.1007/BF00434387.

The effect of timing of a single injection on the toxicity of methotrexate in the rat.单次注射时间对甲氨蝶呤在大鼠体内毒性的影响。

Cancer Chemother Pharmacol. 1982;9(2):114-7. doi: 10.1007/BF00265390.

The practical benefits of pharmacokinetics in the use of antineoplastic agents.药代动力学在抗肿瘤药物使用中的实际益处。

Cancer Chemother Pharmacol. 1980;4(3):139-45. doi: 10.1007/BF00254011.

Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion doses.

Eur J Clin Pharmacol. 1985;28(4):457-62. doi: 10.1007/BF00544367.

Pharmacokinetics of (-)-folinic acid after oral and intravenous administration of the racemate.

Br J Clin Pharmacol. 1989 Sep;28(3):289-95. doi: 10.1111/j.1365-2125.1989.tb05429.x.

Critical factors for the reversal of methotrexate cytotoxicity by folinic acid.亚叶酸钙逆转甲氨蝶呤细胞毒性的关键因素。

Br J Cancer. 1991 Feb;63(2):303-7. doi: 10.1038/bjc.1991.70.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验